Immunovant Inc. Common Stock vs PBF Energy Inc. Class A Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.25B), while PBF Energy Inc. Class A Common Stock trades at $88.64 (market cap $10.59B). The key difference: PBF Energy Inc. Class A Common Stock is the larger of the two by market cap, and PBF Energy Inc. Class A Common Stock pays a 1.23% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and PBF Energy Inc. Class A Common Stock for 0 Days on average.
| IMVT | PBF | |
|---|---|---|
Market Cap | $6.25B | $10.59B |
Volume | 1,755,411 | 3,004,875 |
Sector | Health | Energy |
52-Week High | $44.96 | $89.34 |
52-Week Low | $17.03 | $26.02 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $12.21B |
Dividend Yield | — | 1.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →PBF Energy refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics assets supporting its refining business.
Read more on PBF →